Montelukast Sodium Tablet, Chewable
Product Images NDC 62175-204

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 62175-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Montelukast Sodium Tablets And Chewable Tablets 1)

Figure 1 (Montelukast Sodium Tablets And Chewable Tablets 1)
This is a graph depicting the change in height (in cm) of individuals undergoing treatment with Montelukast Sodium 5mg, Beclomethasone 336mcg, or Placebo over 56 weeks. The x-axis shows the weeks on treatment ranging from -19 to 56, and the y-axis shows the change in height (in cm) ranging from -40 to +48.*
FDA Label Image

Chemical Structure (Montelukast Sodium Tablets And Chewable Tablets 2)

Chemical Structure (Montelukast Sodium Tablets And Chewable Tablets 2)
FDA Label Image

Figure 2 (Montelukast Sodium Tablets And Chewable Tablets 3)

Figure 2 (Montelukast Sodium Tablets And Chewable Tablets 3)
FDA Label Image

4 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 4)

4 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 4)
This is a description for a medication called "Montelukast" that comes in the form of chewable tablets. The medication is intended for pediatric patients between 2-5 years of age and is used to treat asthma and other breathing problems. The recommended dosage is 4.2 mg per day and it must be kept at controlled room temperature. The medication comes with a Medication Guide for each patient and is distributed by a company named Lannett. The text also includes instructions for storing the medication and a warning to keep it out of reach of children and pets.*
FDA Label Image

5 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 5)

5 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 5)
Eachtoblt antns 5.2 g is the name of a chewable tablet medication with NDC number 62175-205-46, containing Montelukast Sodium, equivalent to Montelukast. The medication is intended for pediatric patients aged 6-14 years with usual dosages accompanying Sodium. The tablets should be kept in a cool and dry place, stored at temperatures ranging from 15°C to 30°C (59-86°F). Patients should read the accompanying Medication Guide for instructions on usage and dosage. Lonnett Company, Inc. distributes the medication, and printed Medication Guides are available on their website.*
FDA Label Image

10 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 6)

10 mg 90 Count Monte (Montelukast Sodium Tablets And Chewable Tablets 6)
Each tablet of Montelukast Sodium contains 104 mg of Mortelukest Sadum equivalent to 1010 mg of Montelkest. Usual dosage information is provided in the accompanying dialo. It is important to keep this medicine and all drugs out of the reach of children. This medicine should be stored at temperatures ranging from 25°C (77°F) with permissible fluctuations to 15-30°C (59-86°F) [See USP Controlled Room Temperature] to protect it from moisture and light. The medicine is distributed by Lanett Company and comes in a protective packaging to retain its efficacy. For further guidance on the uses and dosage instructions, please obtain simplified guides either from the website jormett.corn/rred-quide/imortelukagt or print medication guides. 90 tablets are available in each package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.